Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Camac

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Haixia Wang, Zheming Ruan, James J Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virusXiaofan Zheng, Thomas W Hudyma, Scott W Martin, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
Journal of Medicinal Chemistry|February 16, 2022
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 InhibitorsRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)Jun Li, Lawrence J Kennedy, Steven J Walker, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)Shung C Wu, David Yoon, Janice Chin, et al.
Archives of Biochemistry and Biophysics|February 8, 2003
Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzymeLisa M Kopcho, Jianhong Ma, Jovita Marcinkeviciene, et al.
Journal of Medicinal Chemistry|May 25, 2017
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 InhibitorXiang-Yang Ye, Stephanie Y Chen, Shung Wu, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Haixia Wang, Zheming Ruan, James J Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virusXiaofan Zheng, Thomas W Hudyma, Scott W Martin, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
Journal of Medicinal Chemistry|February 16, 2022
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 InhibitorsRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)Jun Li, Lawrence J Kennedy, Steven J Walker, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)Shung C Wu, David Yoon, Janice Chin, et al.
Archives of Biochemistry and Biophysics|February 8, 2003
Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzymeLisa M Kopcho, Jianhong Ma, Jovita Marcinkeviciene, et al.
Journal of Medicinal Chemistry|May 25, 2017
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 InhibitorXiang-Yang Ye, Stephanie Y Chen, Shung Wu, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 2